P, G., P, M., H, C., & DA, I. (2025). Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy. Lupus, 34(4), 405. https://doi.org/10.1177/09612033251322927
Chicago Style (17th ed.) CitationP, Gaspar, Mittal P, Cohen H, and Isenberg DA. "Risk Factors for Bleeding in Patients with Thrombotic Antiphospholipid Syndrome During Antithrombotic Therapy." Lupus 34, no. 4 (2025): 405. https://doi.org/10.1177/09612033251322927.
MLA (9th ed.) CitationP, Gaspar, et al. "Risk Factors for Bleeding in Patients with Thrombotic Antiphospholipid Syndrome During Antithrombotic Therapy." Lupus, vol. 34, no. 4, 2025, p. 405, https://doi.org/10.1177/09612033251322927.
Warning: These citations may not always be 100% accurate.